Senators want FDA to answer unsettled questions on biosimilars

Nine Republican members of the Senate Health, Education, Labor, and Pensions (HELP) Committee sent a (see BioCentury Extra, April 28).

Also this week, FDA's Center for Drug Evaluation and Research (CDER) announced its intention to publish in 2015 its guidance on non-proprietary naming for biosimilars. ...